After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma
about
Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment.Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantationIncomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signalingRadiofrequency Ablation versus Liver Resection for Colorectal Cancer Liver Metastasis: An Updated Systematic Review and Meta-analysisLocal tumor progression patterns after radiofrequency ablation of colorectal cancer liver metastasesMultimodality therapy and liver transplantation for hepatocellular carcinoma: a 14-year prospective analysis of outcomes.Long noncoding RNA expression profiles in sub-lethal heat-treated hepatoma carcinoma cells.Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment.Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma.Insufficient radiofrequency ablation promotes the growth of non-small cell lung cancer cells through PI3K/Akt/HIF-1α signals.Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines.Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinomaRadiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: is ablative margin of more than 1 cm justified?Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways.Elevated plasma migration inhibitory factor in hypertension-hyperlipidemia patients correlates with impaired endothelial function.Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment.TGF-β Mediated Crosstalk Between Malignant Hepatocyte and Tumor Microenvironment in Hepatocellular Carcinoma.Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinomaDisease monitoring of hepatocellular carcinoma through metabolomics.Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis.Short-term and long-term outcomes of laparoscopic hepatectomy, microwave ablation, and open hepatectomy for small hepatocellular carcinoma: a 5-year experience in a single center.Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation.Role of liver ICAM-1 in metastasis.Surgical and Pathological Changes after Radiofrequency Ablation of Thyroid Nodules.Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma.Heat Stress and Hepatic Laser Thermal Ablation Induce Hepatocellular Carcinoma Growth: Role of PI3K/mTOR/AKT Signaling.
P2860
Q26741499-E304F09A-9821-460A-832E-93A724DEFA76Q26772329-2FC1DEFD-95D6-4A42-944D-8F5E6C28C754Q27318569-27380AD5-7BE9-42E0-9A4D-DB64A72A9B15Q30240094-A4CF77CA-518A-4376-B5AD-901EF465C526Q30370000-A420B18E-1B21-4D41-8C17-6DBC088463C9Q33869846-4919FD2E-7AA6-479B-B13C-2BFB93984935Q33922769-B9ED2CC9-3B81-406B-9354-31A16DD135E8Q35567648-B2F0D316-1DF5-48D0-8C84-633AB51C1136Q35856250-4C806B45-E608-4B60-908C-1D6FA771D612Q36937807-A5436B80-1C9D-4C43-9AF7-ED50355873F3Q36949594-276FEFC5-1D4B-43D4-A138-8855858E60F4Q37115310-772F1887-CB02-4561-A9EF-53B5F2F74EB6Q37301807-A5F79E14-DB09-48F9-AEE5-5174E7470A32Q37317451-E66FC7EA-C8FB-471F-8790-A5165260498BQ37348249-4155BF30-E47B-402A-9154-7FC63D5CCCB4Q37384162-9C30B3A0-9CEA-4638-BD88-5B0283766EAFQ37581359-C96E51B0-23EF-48CB-98DC-5CB28FE34C3AQ37705967-E478C935-4535-454D-AE46-54A1A2B37AC7Q38207013-D37FF05A-A698-4CC9-9CF3-426CC0182C33Q38768256-BA5F645E-64CF-46C3-9C9B-A2004A45947DQ38787495-DACED759-BAEF-49EE-A980-189D5DE4CAD6Q39528394-18D59390-CFEA-4243-90E3-9773EE938504Q40044969-E71DD448-49E4-46FA-82DD-AB98DE9AA08BQ41701847-A58A4D9C-684B-4217-8E72-CA47DE99E33DQ42413389-D055B59D-9DF8-443C-84AA-46C0439AD8AEQ53655244-72058F08-DF79-424F-BAA0-AF97303F7C62Q54979563-64195A5B-A0F2-4569-B31C-8FD05F19EB0D
P2860
After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
After insufficient radiofreque ...... idual hepatocellular carcinoma
@ast
After insufficient radiofreque ...... idual hepatocellular carcinoma
@en
type
label
After insufficient radiofreque ...... idual hepatocellular carcinoma
@ast
After insufficient radiofreque ...... idual hepatocellular carcinoma
@en
prefLabel
After insufficient radiofreque ...... idual hepatocellular carcinoma
@ast
After insufficient radiofreque ...... idual hepatocellular carcinoma
@en
P2093
P2860
P356
P1476
After insufficient radiofreque ...... idual hepatocellular carcinoma
@en
P2093
Huichuan Sun
Jinge Kong
Lemin Zheng
Lingqun Kong
Wenbing Sun
Xuemei Ding
P2860
P2888
P356
10.1186/1479-5876-10-230
P577
2012-11-21T00:00:00Z
P5875
P6179
1039855866